• Visiting address

    BMC, C13

    221 84 Lund


Unit profile



We use molecular genetic techniques such as next-generation sequencing and SNP array analysis to identify and characterize acquired genetic aberrations in aneuploid malignancies, with a particular focus on high hyperdiploid and hypodiploid acute lymphoblastic leukemia and anaplastic thyroid cancer. Primary aim To understand how massive chromosomal gain and loss arise and affect cancer cells. Secondary aim To identify novel treatment-stratifying markers and new therapeutic targets in aneuploid malignancies.

UKÄ subject classification

  • Cancer and Oncology
  • Hematology


  • Leukemia
  • high hyperdiploid
  • anaplastic thyroid
  • cancer genomics
  • aneuploidy
  • hypodiploidy


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or